| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 7117 | 2008 |
| Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004 | 2372 | 2004 |
| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1935 | 2019 |
| Non-recognition of depression and other non-motor symptoms in Parkinson's disease LM Shulman, RL Taback, AA Rabinstein, WJ Weiner Parkinsonism & related disorders 8 (3), 193-197, 2002 | 972 | 2002 |
| A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study Parkinson Study Group Archives of Neurology 59 (12), 1937-1943, 2002 | 704 | 2002 |
| Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review):[RETIRED] Report of the Quality Standards … JM Miyasaki, K Shannon, V Voon, B Ravina, G Kleiner-Fisman, ... Neurology 66 (7), 996-1002, 2006 | 703 | 2006 |
| Comorbidity of the nonmotor symptoms of Parkinson's disease LM Shulman, RL Taback, J Bean, WJ Weiner Movement disorders: official journal of the Movement Disorder Society 16 (3 …, 2001 | 636 | 2001 |
| The clinically important difference on the unified Parkinson's disease rating scale LM Shulman, AL Gruber-Baldini, KE Anderson, PS Fishman, SG Reich, ... Archives of neurology 67 (1), 64-70, 2010 | 587 | 2010 |
| A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study Parkinson Study Group Archives of Neurology 62 (2), 241-248, 2005 | 549 | 2005 |
| Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease LM Shulman, LI Katzel, FM Ivey, JD Sorkin, K Favors, KE Anderson, ... JAMA neurology 70 (2), 183-190, 2013 | 481 | 2013 |
| Fatigue in Parkinson's disease: a review JH Friedman, RG Brown, C Comella, CE Garber, LB Krupp, JS Lou, ... Movement disorders: official journal of the Movement Disorder Society 22 (3 …, 2007 | 448 | 2007 |
| A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease IH Richard, MP McDermott, R Kurlan, JM Lyness, PG Como, N Pearson, ... Neurology 78 (16), 1229-1236, 2012 | 405 | 2012 |
| The evolution of disability in Parkinson disease LM Shulman, AL Gruber‐Baldini, KE Anderson, CG Vaughan, SG Reich, ... Movement disorders 23 (6), 790-796, 2008 | 377 | 2008 |
| Movement disorders: a comprehensive survey WJ Weiner, AE Lang (No Title), 1989 | 344* | 1989 |
| Parkinson's disease age at onset genome‐wide association study: defining heritability, genetic loci, and α‐synuclein mechanisms C Blauwendraat, K Heilbron, CL Vallerga, S Bandres‐Ciga, R Von Coelln, ... Movement Disorders 34 (6), 866-875, 2019 | 326 | 2019 |
| Validation of the PROMIS® measures of self-efficacy for managing chronic conditions AL Gruber-Baldini, C Velozo, S Romero, LM Shulman Quality of Life Research 26, 1915-1924, 2017 | 304 | 2017 |
| Gender differences in Parkinson's disease LM Shulman Gender medicine 4 (1), 8-18, 2007 | 277 | 2007 |
| The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care RE Jensen, NE Rothrock, EM DeWitt, B Spiegel, CA Tucker, HM Crane, ... Medical care 53 (2), 153-159, 2015 | 254 | 2015 |
| Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations RA Hauser, LM Shulman, JM Trugman, JW Roberts, A Mori, R Ballerini, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 240 | 2008 |
| Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ... Brain 143 (1), 234-248, 2020 | 223 | 2020 |
